PDCD1LG2 and non-small cell lung carcinoma: In non-small cell lung cancer (NSCLC) patients, Nazareth et al. have demonstrated that CAFs constitutively express the B7H1 and B7DC molecules (15) and their blocking completely restores activation of tumor-associated T cells.